Total Synthesis, Semisynthesis and Analogue Synthesis of Bioactive Marine Natural Products

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: 31 August 2025 | Viewed by 80

Special Issue Editor

School of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, UK
Interests: natural products; medicinal chemistry; total synthesis; epigenetics

Special Issue Information

Dear Colleagues,                

The oceans, representing 70% of the Earth’s surface, are a tremendous source of biodiversity. This is reflected in the pool of marine natural products that is ever increasing. Many of these secondary metabolites contain scaffolds that are unique and arise from biosynthetic pathways absent in terrestrial organisms. Many possess potent biological activity including approved drugs such as zinconotide, ecteinascidin 743, and plitidepsin. Eribulin, a synthetic analogue of halichondrin B, is another example that showcases the potential of marine natural products for lead discovery. In this Special Issue, we welcome contributions related to the synthesis, design, and biological activity of marine bioactive compounds and their derivatives. If you need further information, please feel free to contact me.

Dr. A. Ganesan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • marine natural products
  • total synthesis
  • semisynthesis
  • biological activity
  • lead discovery and optimisation
  • medicinal chemistry

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop